We-met platform

La plateforme Inserm "We-Met" a été fondé en 2015 à Toulouse pour apporter des solutions innovantes autour de la recherche en biochimie fonctionnelle

[Branka HORVAT @brankahorvat88]

Covid-19. SARS-CoV-2 réveille d’anciens gènes rétroviraux via https://t.co/OPeYpYwHfm

[I2MC-Toulouse @I2mcT]

Next week at our center we will focus on quality-of-life and working conditions in our center. There will be several sessions at noon during your lunchbreak. The focus will be on "sport". Check the screens. @I2MC_PhD_Post @InsermOccPy @Inserm

[We-met platform @MetPlatform]

A great annual meeting @hervcov !
Thank you for the fantastic organisation and the great time we had together! @FrascatiScienza @ClaudiaMatteuc5
Back to Toulouse for @MetPlatform @I2mcT @InsermOccPy

[Inserm Transfert @InsermTransfert]

@InsermTransfert, partenaire du projet @hervcov, @unitorvergata 8-9 juin
Projet #horizoneurope, coordonné par @brankahorvat88, @Inserm vise à comprendre le rôle de la protéine HERV-W et développer des marqueurs et des cibles thérapeutiques pour un traitement du #Covid-19.

[We-met platform @MetPlatform]

@MetPlatform is in the HERVCOV Annual Meeting!

@InsermOccPy @I2mcT @hervcov

[Chiara Cipriani @Ch_Cipriani]

Let’s start with the HERVCOV General Annual Meeting @hervcov @HorizonEU •AMAZING• #HERV #COVID19 #PostCovid

@vita_petrone @M_Fanelli_ @ClaudiaMatteuc5 @emanuelabalest5

https://t.co/cIYQJWadpq

[HERVCOV Project @hervcov]

🧑‍🔬 @Inserm and We-Met are Hervcov Project partner.
#hervcov #hervcovpills #hervcovproject #hervcovpeople #longcovid #research #reserachers #researchlife #inserm #wemet

[GeNeuro @GeneuroO]

Lyon. La société lyonnaise GeNeuro sur la piste d’un traitement contre le Covid long - https://t.co/PkwVHTc9GK

#CovidLong #PostCovid #temelimab #HERV

[We-met platform @MetPlatform]

A superb European User Meeting in Amsterdam with presentation of our facility
#EIUM @biotechne @I2mcT

[ApresJ20 - Association Covid Long France @apresj20]

⬇️Toc Toc @FrcsBraun #BrigitteAutran @agenceANRS
Le #CovidLong : 3ème trouble neurologique le plus courant aux 🇺🇸!

"Si cela ne suffit pas à créer l'urgence, qu'est-ce que c'est?" alerte @IgorKoralnik.

https://t.co/3CGxN0uNCr

[Inserm Auvergne-Rhône-Alpes @InsermAuRA]

#HERVCOV vise à étudier l'effet de l'infection #SARSCoV2 sur l'activation de rétrovirus endogènes humains et la pathologie induite chez les patients #COVID19. Ce projet est coordonné @brankahorvat88 @Inserm au @CIRI_Lyon @ENSdeLyon @CNRS_dr07 @UnivLyon1 @UEFrance

[Frascati Scienza @FrascatiScienza]

Italian team is ready to start #hervcov

[HERVCOV Project @hervcov]

Group shot from the #Hervcov kick off meeting in Lyon. Let’s do Science! #HorizonEU

[GeNeuro @GeneuroO]

$GNRO will contribute to the #HERVCOV research effort funded by the #EuropeanUnion to advance on personalized treatments in populations affected by #HERV W-ENV expression.
#postcovid #longcovid #covidlong #pasc

https://t.co/KnMUlbS76J

[Inserm Transfert @InsermTransfert]

Inserm Transfert est partenaire du projet @hervcov projet de #médecine de précision lié aux #rétrovirus endogènes humains et axé sur le #COVID19
@Inserm

[HERVCOV Project @hervcov]

The study behind #HERVCOV is focused on the HERV-W-ENV protein, a molecule found to be induced during #SARSCoV2 infection and present at high levels in the
blood of patients with severe #COVID19 and has been associated to the so-called #LongCovid disorders.

[HERVCOV Project @hervcov]

#HERVCOV is the name of the project funded by the European Commission with a grant of almost 7 million euros that involves research centers, companies and
associations from Croatia, France, Greece, Italy and Spain

[GeNeuro @GeneuroO]

ProTEct-MS Phase 2 trial confirms safety of higher doses of #temelimab and synergistic potential to address #neurodegeneration on top of anti-inflammatory treatment in multiple sclerosis
#fightmsprogression #HERVs #MS
https://t.co/sBZe6dXP1q

[GeNeuro @GeneuroO]

Covid : découverte d’un rétrovirus endogène humain associé à une forme grave https://t.co/FUaZJExVig via @science_et_vie